https://www.prnewswire.co.uk/news-releases/epivax-signs-first-commercial-license-for-tregitope-technology-620390943.html
EpiVax Signs First Commercial License for Tregitope Technology
/PRNewswire/ -- Providence-based biotechnology company EpiVax, Inc. ("EpiVax") has licensed its novel immune-modulating technology to an undisclosed global...
commercial licenseepivaxsignsfirsttregitope